Besides the absence of gene intersection between the signatures, all four achieve the same results: patients with IDHmut tumors presented a lower autophagy-related risk signature compared to IDH wild-type (IDHwt) gliomas, denoting an increased autophagy activation in IDHwt GBMs (136, 137, 196, 197). This evidence concerns the gene IDH1 and central nervous system cancer.